Reagenzgläser

Vesalius Biocapital

A European life sciences venture capital investor

.

About us

News

Vesalius News

07/28/2021

Topas Therapeutics raises $40M series B

07/06/2021

SWORD HEALTH raises $85M series C

06/10/2021

DEARhealth: CE marking to MDR